Related Experiment Video
Updated: Jul 20, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Improved outcomes for hospitalized asthmatic children using a clinical pathway
C S Kelly1, C L Andersen, J P Pestian
1Department of Pediatrics, Eastern Virginia Medical School, Children's Hospital of The King's Daughter, Norfolk 23507, USA.
Insights
Implementing an asthma clinical pathway for children significantly reduced hospital stays and costs. It also improved patient education and home care management for asthma patients.
Area of Science:
- Pediatric Pulmonology
- Healthcare Management
- Clinical Effectiveness Research
Background:
- Asthma clinical pathways are increasingly utilized in healthcare settings.
- However, there is a limited number of controlled studies assessing their clinical and economic benefits.
- This study addresses the need for evidence on the effectiveness of asthma clinical pathways.
Purpose of the Study:
- To determine the impact of an inpatient asthma clinical pathway on the cost and quality of care for pediatric asthma patients.
- To provide data on the effectiveness of standardized care protocols in managing childhood asthma exacerbations.
Main Methods:
- A retrospective cohort study compared 34 children treated with an asthma clinical pathway to 34 matched controls.
- Patients were matched based on age, race, gender, comorbidities, asthma severity, ICU admission, and admission time.
- Key outcomes included length of stay, total costs, readmission rates, inpatient management, and discharge medications.
Main Results:
- The clinical pathway group had a significantly shorter length of stay (36 vs. 71 hours, P < .001) and lower total costs ($1685 vs. $2829, P < .001).
- Pathway patients were more likely to receive asthma education (65% vs. 18%, P < .001), be discharged with controller medications (88% vs. 53%, P < .01), and have home use devices like peak flow meters (57% vs. 23%, P < .05) and spacers (100% vs. 71%, P < .001).
Conclusions:
- The inpatient asthma clinical pathway effectively reduced length of stay and healthcare costs.
- The pathway also enhanced the quality of care for hospitalized children with asthma through improved education and discharge planning.
Background:
Although asthma clinical pathways are used with increasing frequency, few controlled studies have evaluated the clinical and cost effectiveness of these pathways.
Objective:
To evaluate the effect of an inpatient asthma clinical pathway on cost and quality of care for children with asthma.
Methods:
One hundred forty-nine children were treated for status asthmaticus using an asthma clinical pathway in a children's hospital between September and December 1997. Thirty-four of 149 children treated with the clinical pathway were randomly selected. A retrospective cohort control group of non-pathway patients (N = 34) was matched with each pathway patient by age, race, gender, co-morbidities, asthma severity score, ICU admission, and time of year admitted. Differences between the two groups in length of stay, total costs, readmission rate, inpatient management, and discharge medications were compared.
Results:
Length of stay was significantly lower in the clinical pathway group compared with the control group (36 hours versus 71 hours, P < .001) and total costs decreased significantly ($1685 versus $2829, P < .001) as a result of the pathway. Asthmatic children on the clinical pathway were significantly more likely than the control group to complete asthma teaching while hospitalized (65% versus 18%, P < .001), to be discharged with a prescription for a controller medication (88% versus 53%, P < .01), and to have a peak flow meter (57% versus 23%, P < .05) and a spacer device (100% versus 71%, P < .001) for home use.
Conclusion:
Implementation of this inpatient clinical pathway led to a decrease in length of stay and a reduction in total cost while improving quality of care for hospitalized asthmatic children.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Asthma III: Clinical Manifestations